Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 15 (2%) | |
| Anticipated shortage: | 4 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
1 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130641 |
| MYLAN-VARDENAFIL | 20MG | TABLET | Resolved | 2022-03-02 | 2022-04-27 | 155830 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| MYLAN-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149967 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149970 |
| WIXELA INHUB | 50MCG 500MCG | POWDER | Resolved | 2022-03-11 | 2022-03-16 | 156586 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2022-02-23 | 2022-03-10 | 155442 |
| MYLAN-VARDENAFIL | 5MG | TABLET | Avoided shortage | 2021-12-21 | 2022-03-09 | 151666 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2022-02-02 | 2022-02-25 | 154043 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-10-13 | 2022-02-15 | 25895 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-08-01 | 2022-02-15 | 17787 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 200MG 300MG | TABLET | Resolved | 2022-01-26 | 2022-02-04 | 153490 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-01-18 | 2022-01-26 | 152983 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6982 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6979 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-12-21 | 2022-01-04 | 151663 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
| MYLAN-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6720 |
| MYLAN-PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6717 |
| MYLAN-PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6714 |
| MYLAN-PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6710 |
| MYLAN-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6707 |
| MYLAN-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6704 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| MYLAN-EZETIMIBE | 10MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6695 |
| MYLAN-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6692 |
| MYLAN-METOPROLOL (TYPE L) | 100MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6673 |
| MYLAN-MEMANTINE | 10MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6667 |
| MYLAN-METOPROLOL (TYPE L) | 25MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6670 |